Drug recall · June 26, 2019
Myorisan recall
Why: Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Myorisan (isotretinoin capsules, USP), 40 mg, packaged in cartons of 30 Capsules containing 3 x 10 Prescription Packs, Rx Only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forest, IL 60045, NDC 61748-304-13
- Lots / codes
Lot#: V30M56A, Exp 9/20
- Quantity
- 16,216 cartons
- Company
- Akorn Inc, Lake Forest, IL
- Distribution
- Nationwide USA
- Initiated
- June 7, 2019 · Voluntary: Firm initiated
- Classified
- June 17, 2019
- Reported
- June 26, 2019
- Ended
- July 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Isotretinoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.